Merck Settles Cholesterol Drug Lawsuits for $688M
Merck will pay $688 million to settle two shareholder lawsuits over a delay in the disclosure of trial results for its cholesterol druf Vytorin.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here